{"name":"Aprobarbital","slug":"aprobarbital","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Allypropymal","Alurate","Allylpropymal","Aprobarbitone","Allonal","Allional","Aprozal","Numal","Alurate elixir verdum","5-Allyl-5-isopropylbarbituric acid"],"brands":[],"scraped":true,"has_structure":true,"cid":6464,"classes":[],"families":[{"name":"barbiturate","href":"/substituted/barbiturate"}],"physical":[{"label":"Molecular mass","value":"210.23 g/mol","copyable":false},{"label":"Appearance","value":"CRYSTALS","copyable":false},{"label":"Taste","value":"SLIGHTLY BITTER","copyable":false},{"label":"Melting point","value":"141 °C","copyable":false},{"label":"Decomposition","value":"When heated to decomp it emits toxic fumes of oxides of nitrogen. /Aprobarbital sodium/","copyable":false},{"label":"Solubility","value":"4080 mg/L (at 25 °C)","copyable":false},{"label":"Predicted LogP","value":"1.1","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>10</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"5-propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione","copyable":true},{"label":"SMILES","value":"CC(C)C1(C(=O)NC(=O)NC1=O)CC=C","copyable":true},{"label":"InChI","value":"InChI=1S/C10H14N2O3/c1-4-5-10(6(2)3)7(13)11-9(15)12-8(10)14/h4,6H,1,5H2,2-3H3,(H2,11,12,13,14,15)","copyable":true},{"label":"InChIKey","value":"UORJNBVJVRLXMQ-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"77-02-1","copyable":true},{"label":"UNII","value":"Q0YKG9L6RF","copyable":true},{"label":"PubChem CID","value":"6464","copyable":true}],"pharmacokinetics":[],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N05","description":"Psycholeptics"},{"code":"N05C","description":"Hypnotics and sedatives"},{"code":"N05CA","description":"Barbiturates, plain"},{"code":"N05CA05","description":"Aprobarbital"}],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"GABRA1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":32,"contraindicated":0}],"mechanism":"Aprobarbital (like all barbiturates) works by binding to the GABAA receptor at either the alpha or the beta sub unit.  These are binding sites that are distinct from GABA itself and also distinct from the benzodiazepine binding site. Like benzodiazepines, barbiturates potentiate the effect of GABA at this receptor.  This GABAA receptor binding decreases input resistance, depresses burst and tonic firing, especially in ventrobasal and intralaminar neurons, while at the same time increasing burst duration and mean conductance at individual chloride channels; this increases both the amplitude and decay time of inhibitory postsynaptic currents.  In addition to this GABA-ergic effect, barbiturates also block the AMPA receptor, a subtype of glutamate receptor. Glutamate is the principal excitatory neurotransmitter in the mammalian CNS.  Aprobarbital also appears to bind neuronal nicotinic acetylcholine receptors.","side_effects":null,"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Aprobarbital"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/6464"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q411940"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01352"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL7863"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A2791"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=77-02-1"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015441"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07826"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8022616"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Aprobarbital"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/Q0YKG9L6RF"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 6464, Aprobarbital. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/6464>https://pubchem.ncbi.nlm.nih.gov/compound/6464</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Aprobarbital. UNII: Q0YKG9L6RF. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Q0YKG9L6RF>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Q0YKG9L6RF</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 18:01:31","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 18:01:27","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 18:01:27","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 18:01:27","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 18:01:27","note":"hmdb.ca refused automated access to HMDB0015441"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 18:01:29","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 18:01:26","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 18:01:27","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 18:01:27","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 18:01:27","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 18:01:27","note":null}],"description":"Aprobarbital is a  substance."}